Page last updated: 2024-08-16

tibolone and Bone Loss, Osteoclastic

tibolone has been researched along with Bone Loss, Osteoclastic in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (46.15)18.2507
2000's6 (46.15)29.6817
2010's0 (0.00)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Barik, A; Byram, PK; Chakravorty, N; Ray, SK; Sinha, R1
Byrjalsen, I; Christiansen, C; Karsdal, MA; Leeming, DJ1
Krieg, MA; Lamy, O1
Arabi, A; Garnero, P; Porcher, R; Roux, C1
Benussi, C; Bevilacqua, G; Cappagli, B; Ciaponi, M; Gambacciani, M; Genazzani, AR; Monteleone, P1
Parfitt, AM; Riggs, BL1
Akgul, C; Canbaz, M; Vural, P1
Compston, JE; Croucher, PI; Garrahan, NJ; Lindsay, PC; Shaw, RW; Yamaguchi, K1
Hosoi, T; Ikegami, A; Kasugai, Y; Matsuo, K; Ohashi, M; Orimo, H; Ouchi, Y; Sukamoto, T1
Alexandersen, P; Bjarnason, NH; Christgau, S; Christiansen, C; Fledelius, C; Herling, C; Qvist, P; Ravn, P; Rosenquist, C1
Alhava, E; Arnala, I; Jääskeläinen, K; Kröger, H; Parviainen, MT1
Berning, B; Coelingh Bennink, HJ; Fauser, BC; Kuiper, JW; van Kuijk, C1
Christiansen, C1

Reviews

2 review(s) available for tibolone and Bone Loss, Osteoclastic

ArticleYear
[Hormone replacement therapy and its derivatives in the prevention and treatment of osteoporosis].
    Revue medicale de la Suisse romande, 2002, Volume: 122, Issue:8

    Topics: Aged; Bone Density; Bone Resorption; Dose-Response Relationship, Drug; Estrogen Receptor Modulators; Female; Fractures, Bone; Hormone Replacement Therapy; Humans; Middle Aged; Norpregnenes; Osteoporosis; Randomized Controlled Trials as Topic

2002
Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2005, Volume: 20, Issue:2

    Topics: Adult; Age Factors; Aged; Aging; Anabolic Agents; Bone and Bones; Bone Density; Bone Development; Bone Remodeling; Bone Resorption; Female; Humans; Middle Aged; Models, Biological; Norpregnenes; Organometallic Compounds; Osteoblasts; Osteoporosis; Osteoporosis, Postmenopausal; Teriparatide; Terminology as Topic; Testosterone; Thiophenes; Time Factors

2005

Trials

7 trial(s) available for tibolone and Bone Loss, Osteoclastic

ArticleYear
Tibolone inhibits bone resorption without secondary positive effects on cartilage degradation.
    BMC musculoskeletal disorders, 2008, Nov-18, Volume: 9

    Topics: Aged; Bone and Bones; Bone Resorption; Cartilage, Articular; Collagen Type XI; Collagen Type XII; Dose-Response Relationship, Drug; Double-Blind Method; Estrogen Receptor Modulators; Female; Humans; Longitudinal Studies; Middle Aged; Norpregnenes; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone

2008
Serum leptin as a determinant of bone resorption in healthy postmenopausal women.
    Bone, 2003, Volume: 33, Issue:5

    Topics: Aged; Biomarkers; Bone Density; Bone Resorption; Double-Blind Method; Female; Humans; Leptin; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Prospective Studies; Statistics, Nonparametric

2003
A longitudinal evaluation of the effect of two doses of tibolone on bone density and metabolism in early postmenopausal women.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2004, Volume: 18, Issue:1

    Topics: Administration, Oral; Androgen Antagonists; Bone Density; Bone Resorption; Calcium, Dietary; Drug Administration Schedule; Female; Humans; Longitudinal Studies; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Prospective Studies; Surveys and Questionnaires; Treatment Outcome

2004
The effects of gonadotrophin-releasing hormone agonists on iliac crest cancellous bone structure in women with endometriosis.
    Bone, 1995, Volume: 16, Issue:2

    Topics: Adult; Anabolic Agents; Biopsy; Bone Density; Bone Resorption; Drug Therapy, Combination; Endometriosis; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Ilium; Norpregnenes; Osteoporosis, Postmenopausal; Premenopause; Triptorelin Pamoate

1995
Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides.
    Clinical chemistry, 1998, Volume: 44, Issue:11

    Topics: Aged; Biomarkers; Bone Density; Bone Resorption; Collagen; Collagen Type I; Diphosphonates; Enzyme-Linked Immunosorbent Assay; Estrogen Replacement Therapy; Female; Humans; Ibandronic Acid; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Peptides; Sensitivity and Specificity

1998
Urinary bone resorption markers in monitoring treatment of symptomatic osteoporosis.
    Clinica chimica acta; international journal of clinical chemistry, 1999, Volume: 279, Issue:1-2

    Topics: Aged; Anabolic Agents; Biomarkers; Bone Resorption; Calcium; Collagen; Collagen Type I; Double-Blind Method; Female; Humans; Hydroxyproline; Immunoenzyme Techniques; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Peptides; Placebos; Pyridines

1999
Increased loss of trabecular but not cortical bone density, 1 year after discontinuation of 2 years hormone replacement therapy with Tibolone.
    Maturitas, 1999, Jan-04, Volume: 31, Issue:2

    Topics: Anabolic Agents; Bone Density; Bone Resorption; Double-Blind Method; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Middle Aged; Norpregnenes

1999

Other Studies

4 other study(ies) available for tibolone and Bone Loss, Osteoclastic

ArticleYear
Extensive early mineralization of pre-osteoblasts, inhibition of osteoclastogenesis and faster peri-implant bone healing in osteoporotic rat model: principle effectiveness of bone-specific delivery of Tibolone as evaluated in vitro and in vivo.
    Biomedical materials (Bristol, England), 2020, 11-21, Volume: 15, Issue:6

    Topics: Alkaline Phosphatase; Animals; Bone and Bones; Bone Regeneration; Bone Resorption; Cell Line, Tumor; Cell Survival; Curcumin; Drug Delivery Systems; Female; Humans; In Vitro Techniques; Metals; Mice; Norpregnenes; Osteoblasts; Osteogenesis; Osteoporosis; Ovariectomy; Prostheses and Implants; Rats; Rats, Wistar; RAW 264.7 Cells; Surface Properties; Titanium

2020
Effects of menopause and postmenopausal tibolone treatment on plasma TNFalpha, IL-4, IL-10, IL-12 cytokine pattern and some bone turnover markers.
    Pharmacological research, 2006, Volume: 53, Issue:4

    Topics: Adult; Biomarkers; Bone Resorption; Calcium; Cytokines; Female; Humans; Hydroxyproline; Middle Aged; Norpregnenes; Postmenopause; Premenopause

2006
Effects of tibolone (Org OD14) treatment for 3 months on ovariectomy-induced osteopenia in 8-month-old rats on a low-calcium diet: preventive testing for 3 months.
    Bone, 1998, Volume: 22, Issue:2

    Topics: Administration, Oral; Amino Acids; Anabolic Agents; Animals; Antineoplastic Agents, Hormonal; Biomarkers; Bone Density; Bone Diseases, Metabolic; Bone Resorption; Calcium; Cholesterol; Creatinine; Female; Femur; Humans; Hydroxyproline; Lumbar Vertebrae; Norpregnenes; Osteocalcin; Ovariectomy; Rats; Rats, Sprague-Dawley; Weight Gain

1998
Sex steroid analogs.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 1999, Volume: 9 Suppl 2

    Topics: Animals; Bone Resorption; Breast Neoplasms; Estrogen Antagonists; Female; Gonadal Steroid Hormones; Hormones; Humans; Norpregnenes; Osteoporosis, Postmenopausal; Pyrrolidines; Raloxifene Hydrochloride; Receptors, Estrogen; Risk; Tamoxifen

1999